
Orvispas D 80mg/250mg Tablet
Marketer
Orville Biotek
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Orvispas D 80mg/250mg Tablet
Combiflam D, an 80mg/250mg tablet, treats abdominal pain by relaxing stomach and intestinal muscles, thus alleviating bloating, cramps, and discomfort. Its mechanism involves inhibiting pain-signaling chemicals. Dosage and duration are determined by your physician and should be adhered to; premature discontinuation may exacerbate symptoms. Inform your doctor of all other medications you're using, as interactions may occur. Common, generally transient, side effects include nausea, vomiting, diarrhea, stomach pain, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are possible; avoid driving or tasks demanding concentration until their effect is known. Alcohol consumption should be avoided due to increased dizziness risk. Prior to use, inform your doctor of pregnancy, pregnancy plans, breastfeeding, or existing kidney/liver conditions to ensure appropriate dosage.
Uses of Orvispas D 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Orvispas D 80mg/250mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Orvispas D 80mg/250mg tablets with food.
Common Side effects of Orvispas D 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Orvispas D 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 80mg/250mg Orvispas D tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Orvispas D 80mg/250mg Tablet works:
Each Orvispas D 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces painful abdominal muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of substances triggering abdominal pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Orvispas D 80mg/250mg Tablets is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Orvispas D 80mg/250mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Orvispas D 80mg/250mg tablets with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Orvispas D 80mg/250mg Tablets, a potential side effect of this medication, including vertigo.
KidneyCAUTION
Patients with impaired kidney function should use Orvispas D 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Orvispas D 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Orvispas D 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Orvispas D 80mg/250mg Tablet :
Should you forget to take your Orvispas D 80mg/250mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orvispas D 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
